Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/58136

Registo completo
Campo DCValorIdioma
dc.contributor.authorFelicio, Paula Silvapor
dc.contributor.authorAlemar, Barbarapor
dc.contributor.authorCoelho, Aline Silvapor
dc.contributor.authorBerardinelli, Gustavo Norizpor
dc.contributor.authorMelendez, Matias Eliseopor
dc.contributor.authorLengert, André Van Helvoortpor
dc.contributor.authorMiche Lli, Rodrigo Depieripor
dc.contributor.authorReis, R. M.por
dc.contributor.authorFernandes, Gabriela Carvalhopor
dc.contributor.authorEwald, Ingrid Petronipor
dc.contributor.authorBittar, Camila Matzenbacherpor
dc.contributor.authorNetto, Cristina Brinckmann Oliveirapor
dc.contributor.authorArtigalas, Osvaldopor
dc.contributor.authorPeixoto, Anapor
dc.contributor.authorPinheiro, Manuelapor
dc.contributor.authorTeixeira, Manuel R.por
dc.contributor.authorVargas, Fernando Reglapor
dc.contributor.authorDos Santos, Anna Cláudia Evangelistapor
dc.contributor.authorMoreira, Miguel Angelo Martinspor
dc.contributor.authorAshton-Prolla, Patriciapor
dc.contributor.authorPalmero, Edenir Inêzpor
dc.date.accessioned2019-01-14T11:28:08Z-
dc.date.issued2018-12-
dc.identifier.citationFelicio, P. S., Alemar, B., Coelho, A. S., et. al. (2018). Screening and characterization of BRCA2 c. 156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast. Cancer genetics, 228, 93-97por
dc.identifier.issn2210-7762-
dc.identifier.urihttps://hdl.handle.net/1822/58136-
dc.descriptionAccepted manuscriptpor
dc.description.abstractPortuguese immigration to Brazil occurred in several waves and greatly contributed to the genetic composition of current Brazilian population. In this study, we evaluated the frequency of a Portuguese founder Alu insertion in BRCA2 exon 3 (c.156_157insAlu) among individuals fulfilling Hereditary Breast and Ovarian Cancer (HBOC) syndrome criteria in 1,380 unrelated families originated from three distinct Brazilian States. We identified the c.156_157insAlu BRCA2 mutation in nine (9/1,380; 0.65%) probands analised. In carrier probands, European ancestry had the highest proportion (80%), followed by the African (10%) and Amerindian and in most families with the rearrangement, haplotype analyses were compatible with the Portuguese ancestral haplotype. In conclusion, the present study reports a low albeit relevant frequency of the Portuguese BRCA2 founder mutation c.156_157insAlu in Brazilian patients at-risk for HBOC Brazilian population.por
dc.description.sponsorshipCNPq (408313/2016-1), FAPERGS (PRONEX: 16/2551-0000486-2), Hospital de Clínicas de Porto Alegre (FIPE-HCPA), FINEP-CT-INFRA (02/2010) and FAPESP (2013/24633-2). RMR, EIP and PA-P are recipients of National Council of Technological and Scientific Development (CNPq) scholarshipspor
dc.language.isoengpor
dc.publisherElsevier 1por
dc.rightsclosedAccesspor
dc.subjectBRCA2por
dc.subjectHBOCpor
dc.subjectGenetic screeningpor
dc.subjectAlu elementspor
dc.titleScreening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeastpor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2210776218300590por
oaire.citationStartPage93por
oaire.citationEndPage97por
oaire.citationVolume228-229por
dc.identifier.doi10.1016/j.cancergen.2018.09.001por
dc.identifier.pmid30553478por
dc.subject.fosCiências Médicas::Medicina Básicapor
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.subject.wosScience & Technologypor
sdum.journalCancer Geneticspor
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
felicio2018.pdf
Acesso restrito!
655,33 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID